A Phase I safety, tolerability, and pharmacokinetics study of SPR994, an orally administered carbapenem antibiotic in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Tebipenem pivoxil (Primary)
- Indications Haemophilus infections; Streptococcal infections; Urinary tract infections
- Focus Adverse reactions; Pharmacokinetics
- 24 Oct 2017 New trial record